Impact BioMedical, Inc. (IBO) is a Healthcare · Biotechnology company listed on AMEX. Price $0.59 (+3.26%), Market cap $0.06B, 52-week low–high $0.36 ~ $1.61.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances con
Financial statements, price targets, institutional (13F) holdings and related news for Impact BioMedical, Inc. are updated in real time on BlackAll Trade.
Impact BioMedical, Inc. trades at $0.59 (+3.26%). Real-time quotes and charts are available on BlackAll Trade.
Impact BioMedical, Inc. has a market cap of about $0.06B.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicro